Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B

Clinical trial: A phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B

10.1111/j.1365-2036.2008.03686.x

Saved in:
Bibliographic Details
Main Authors: Lim, S.G., Leung, N., Hann, H.W.L., Lau, G.K.K., Trepo, C., Mommeja-Marin, H., Moxham, C., Sorbel, J., Snow, A., Blum, M.R., Rousseau, F., Marcellin, P.
Other Authors: MEDICINE
Format: Article
Published: 2011
Online Access:http://scholarbank.nus.edu.sg/handle/10635/26670
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Description
Summary:10.1111/j.1365-2036.2008.03686.x

Similar Items